Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126496602 | 12649660 | 2 | F | 201607 | 20160815 | 20160812 | 20160823 | EXP | CN-ASTRAZENECA-2016SE81829 | ASTRAZENECA | 511.00 | MON | F | Y | 0.00000 | 20160823 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126496602 | 12649660 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 126496602 | 12649660 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 126496602 | 12649660 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | 1 | DF | TABLET | TID | ||||||||
| 126496602 | 12649660 | 4 | C | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | 1 | 0 | TABLET | |||||||||||
| 126496602 | 12649660 | 5 | C | SITAGLIPTIN PHOSPHATE/METFORMIN HYDROCHLORIDE | 2 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126496602 | 12649660 | 1 | Diabetes mellitus |
| 126496602 | 12649660 | 2 | Diabetes mellitus |
| 126496602 | 12649660 | 3 | Diabetes mellitus |
| 126496602 | 12649660 | 4 | Diabetes mellitus |
| 126496602 | 12649660 | 5 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126496602 | 12649660 | Abdominal pain | |
| 126496602 | 12649660 | Asthenia | |
| 126496602 | 12649660 | Chest discomfort | |
| 126496602 | 12649660 | Constipation | |
| 126496602 | 12649660 | Diarrhoea | |
| 126496602 | 12649660 | Drug hypersensitivity | |
| 126496602 | 12649660 | Dyspnoea | |
| 126496602 | 12649660 | Lip discolouration | |
| 126496602 | 12649660 | Pruritus generalised | |
| 126496602 | 12649660 | Pyrexia | |
| 126496602 | 12649660 | Rash generalised | |
| 126496602 | 12649660 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126496602 | 12649660 | 1 | 20160705 | 0 | ||
| 126496602 | 12649660 | 2 | 20160716 | 20160717 | 0 | |
| 126496602 | 12649660 | 3 | 20160705 | 20160717 | 0 |